Per a court order, HHS is required to restore this website to its version as of 12:00 AM on January 29, 2025. Information on this page may be modified and/or removed in the future subject to the terms of the court’s order and implemented consistent with applicable law. Any information on this page promoting gender ideology is extremely inaccurate and disconnected from truth. The Trump Administration rejects gender ideology due to the harms and divisiveness it causes. This page does not reflect reality and therefore the Administration and this Department reject it.

Increase the proportion of adults with diabetes and chronic kidney disease who get ACE inhibitors or ARBs — CKD‑05 Data

National Status: Little or no detectable change

  

Most Recent Data:
49.2 percent (2017-20) *

National Target:
58.6 percent  1  *

Desired Direction:
Increase desired

National Baseline:
46.2 percent of adults aged 18 years and over with diagnosed diabetes and chronic kidney disease received recommended medical treatment with ACE inhibitors or ARBs in 2013-16 2 *

* Age adjusted to the year 2000 standard population.

Disparities data are only available for some selections.

View CI in the chart by hovering over a data point.

View SE in the chart by hovering over a data point.

Confidence Interval (CI) not available Standard Error (SE) not available Confidence Interval (CI) and Standard Error (SE) are not available

Display data for:

Adults with diagnosed diabetes and chronic kidney disease receiving recommended treatment, 2013-16 to 2017-20 * ◊
(percent)
Increase desired

Population 2013-16 2017-203
Total
46.2
CI 41.0 / 51.5
SE 4.458
49.2
CI 43.0 / 55.3
SE 6.117

Adults with diagnosed diabetes and chronic kidney disease receiving recommended treatment by Sex, 2013-16 to 2017-20 * ◊
(percent)
Increase desired

Population 2013-16 2017-203
Male
43.7
CI 37.8 / 49.7
SE 4.437
41.1
CI 34.6 / 47.8
SE 6.622
Female
48.9
CI 40.5 / 57.2
SE 6.809
58.8
CI 50.7 / 66.6
SE 7.100

Adults with diagnosed diabetes and chronic kidney disease receiving recommended treatment by Race/Ethnicity, 2013-16 to 2017-20 * ◊
(percent)
Increase desired

Population 2013-16 2017-203
American Indian or Alaska Native only
DSU
DSU
Asian only
DSU
DSU
Native Hawaiian or Other Pacific Islander only
DSU
DSU
Black or African American only
DNA
DNA
White only
DNA
DNA
2 or more races
DSU
DSU
Hispanic or Latino
56.5
CI 48.2 / 64.5
SE 6.467
45.3
CI 33.9 / 57.1
SE 8.830
Mexican American
63.0
CI 52.6 / 72.6
SE 7.174
DSU
Not Hispanic or Latino
DNA
DNA
American Indian or Alaska Native only, not Hispanic or Latino
DSU
DSU
Asian only, not Hispanic or Latino
DSU
DSU
Native Hawaiian or Other Pacific Islander only, not Hispanic or Latino
DSU
DSU
Black or African American only, not Hispanic or Latino
62.5
CI 53.8 / 70.6
SE 6.811
61.1
CI 49.7 / 71.6
SE 11.573
White only, not Hispanic or Latino
37.5
CI 30.6 / 44.8
SE 4.694
43.2
CI 35.6 / 51.0
SE 9.837
2 or more races, not Hispanic or Latino
DSU
DSU

Adults with diagnosed diabetes and chronic kidney disease receiving recommended treatment by Age group, 2013-16 to 2017-20 † ◊
(percent)
Increase desired

Population 2013-16 2017-203
18-44 years
DSU
DSU
18-24 years
DSU
DSU
25-44 years
DSU
DSU
45-64 years
63.3
CI 53.5 / 72.4
SE 4.412
64.3
CI 50.1 / 76.9
SE 6.228
45-54 years
DSU
DSU
55-64 years
70.9
CI 54.4 / 84.1
SE 6.785
65.9
CI 50.7 / 78.9
SE 6.502
65 years and over
63.4
CI 54.2 / 71.9
SE 4.183
72.0
CI 61.1 / 81.3
SE 4.713
65-74 years
62.2
CI 48.7 / 74.4
SE 5.929
73.4
CI 60.7 / 83.8
SE 5.348
75 years and over
65.0
CI 52.4 / 76.2
SE 5.568
70.6
CI 55.6 / 82.9
SE 6.253

Adults with diagnosed diabetes and chronic kidney disease receiving recommended treatment by Educational attainment (25 years and over), 2013-16 to 2017-20 * ◊
(percent)
Increase desired

Population 2013-16 2017-203
Less than High school
35.9
CI 28.7 / 43.6
SE 5.316
56.8
CI 45.6 / 67.6
SE 10.519
High school (including GED or equivalent)
57.2
CI 47.2 / 66.8
SE 7.927
42.0
CI 33.3 / 51.0
SE 4.452
Some college or Associate degree
55.5
CI 46.4 / 64.3
SE 5.510
55.7
CI 44.6 / 66.4
SE 8.991
4-year college degree or more
29.8
CI 16.7 / 45.8
SE 4.727
78.3
CI 67.0 / 87.2
SE 7.879

Adults with diagnosed diabetes and chronic kidney disease receiving recommended treatment by Family income (percent poverty guidelines), 2013-16 to 2017-20 * ◊
(percent)
Increase desired

Population 2013-16 2017-203
<100
48.4
CI 38.8 / 58.0
SE 7.044
52.7
CI 41.9 / 63.2
SE 8.611
100-199
53.9
CI 42.7 / 64.9
SE 11.183
45.9
CI 35.7 / 56.4
SE 12.955
200-399
41.8
CI 30.1 / 54.3
SE 10.518
61.0
CI 48.2 / 72.7
SE 12.465
400+
DSU
32.3
CI 22.5 / 43.4
SE 4.796

Adults with diagnosed diabetes and chronic kidney disease receiving recommended treatment by Health insurance status (under 65 years), 2013-16 to 2017-20 * ◊
(percent)
Increase desired

Population 2013-16 2017-203
Insured
45.8
CI 38.4 / 53.4
SE 5.322
48.5
CI 37.8 / 59.2
SE 8.309
Private
39.6
CI 26.8 / 53.5
SE 8.347
44.8
CI 32.1 / 57.9
SE 8.873
Public
53.8
CI 40.6 / 66.6
SE 10.077
60.6
CI 46.8 / 73.3
SE 11.304
Uninsured
DSU
DSU

Adults with diagnosed diabetes and chronic kidney disease receiving recommended treatment by Geographic location, 2013-16 to 2017-20 * ◊
(percent)
Increase desired

Population 2013-16 2017-203
Geographic location
DNC
DNC

Adults with diagnosed diabetes and chronic kidney disease receiving recommended treatment by Marital status (20 years and over), 2013-16 to 2017-20 * ◊
(percent)
Increase desired

Population 2013-16 2017-203
Married/​Cohabiting partner
52.5
CI 45.2 / 59.8
SE 6.498
54.5
CI 46.2 / 62.6
SE 7.281
Divorced, separated, widowed
56.6
CI 49.0 / 64.1
SE 10.644
48.5
CI 40.6 / 56.3
SE 12.466
Never married
28.9
CI 16.4 / 44.4
SE 5.812
38.2
CI 24.7 / 53.2
SE 5.227

Adults with diagnosed diabetes and chronic kidney disease receiving recommended treatment by Country of birth, 2013-16 to 2017-20 * ◊
(percent)
Increase desired

Population 2013-16 2017-203
US
45.1
CI 39.9 / 50.5
SE 4.153
63.0
CI 57.6 / 68.2
SE 6.202
Outside US
55.7
CI 46.2 / 64.9
SE 10.163
41.6
CI 32.0 / 51.7
SE 6.391

Adults with diagnosed diabetes and chronic kidney disease receiving recommended treatment by Sexual orientation, 2013-16 to 2017-20 * ◊
(percent)
Increase desired

Population 2013-16 2017-203
Sexual orientation
DSU
DSU

Adults with diagnosed diabetes and chronic kidney disease receiving recommended treatment by Gender identity, 2013-16 to 2017-20 * ◊
(percent)
Increase desired

Population 2013-16 2017-203
Gender identity
DNC
DNC

Adults with diagnosed diabetes and chronic kidney disease receiving recommended treatment by Obesity status (20 years and over), 2013-16 to 2017-20 * ◊
(percent)
Increase desired

Population 2013-16 2017-203
With obesity
45.5
CI 38.7 / 52.4
SE 4.927
51.6
CI 43.3 / 59.9
SE 6.445
Without obesity
53.4
CI 45.9 / 60.8
SE 7.905
49.7
CI 42.2 / 57.2
SE 17.418

Disparity